Dashboard
Manage Tickers

BMEA


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

d-boral-capital-maintains-buy-on-biomea-fusion-maintains-16-price-target
D. Boral Capital Maintains Buy on Biomea F...
10/27/2025 12:40:40

D. Boral Capital analyst Jason Kolbert maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and maintains $16 price target.

biomea-fusion-doses-first-patient-in-phase-i-study-of-bmf-650
Biomea Fusion Doses First Patient In Phase...
10/27/2025 12:12:26

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/07/2025 17:06:17

nasdaq-tumbles-200-points-trilogy-metals-shares-spike-higher
Nasdaq Tumbles 200 Points; Trilogy Metals ...
10/07/2025 16:29:00

biomea-fusion-stock-plummets-following-public-offering-diabetes-study
Biomea Fusion Stock Plummets Following Pub...
10/07/2025 14:35:35

Biomea Fusion reported favorable safety for icovamenib in a 52-week diabetes study, alongside a $25 million public offering.

dow-jumps-over-100-points-mccormick-earnings-top-views
Dow Jumps Over 100 Points; McCormick Earni...
10/07/2025 14:20:36

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/07/2025 12:08:21

biomea-fusion-announces-pricing-of-its-underwritten-public-offering-including-11195121-shares-of-common-stock-and-1m-pre-funded-warrants-each-warrant-has-exercise-price-of-250-and-offering-price-per-common-share-and-warrant-is-205
Biomea Fusion Announces Pricing Of Its Und...
10/07/2025 12:05:48

Biomea Fusion, Inc. ("Biomea") (NASDAQ:BMEA), a clinical-stage diabetes and obesity company, today announced the pricin...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
10/06/2025 21:06:27

biomea-fusion-announces-proposed-public-offering-of-securities-no-size-or-amount-disclosed
Biomea Fusion Announces Proposed Public Of...
10/06/2025 20:18:41

Biomea Fusion, Inc. ("Biomea") (NASDAQ:BMEA), a clinical-stage diabetes and obesity company, announced today that it ha...

biomea-fusion-announces-52-week-phase-ii-data-for-icovamenib-in-type-2-diabetes-study-shows-sustained-hba1c-reduction-and-favorable-safety-profile
Biomea Fusion Announces 52-Week Phase II D...
10/06/2025 20:04:28

Icovamenib showed a sustained treatment benefit at Week 52 (9 months past the end of treatment) in the severe insulin-deficient...

d-boral-capital-maintains-buy-on-biomea-fusion-maintains-16-price-target
D. Boral Capital Maintains Buy on Biomea F...
10/03/2025 12:32:26

D. Boral Capital analyst Jason Kolbert maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and maintains $16 price target.

biomea-fusion-presents-data-showing-icovamenib--semaglutide-boosts-t2d-outcomes-fda-clears-ind-for-bmf-650-phase-i-obesity-trial-in-2025
Biomea Fusion Presents Data Showing Icovam...
09/16/2025 11:17:19

this-oddity-tech-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday
This Oddity Tech Analyst Begins Coverage O...
08/28/2025 12:43:21

jefferies-initiates-coverage-on-biomea-fusion-with-buy-rating-announces-price-target-of-5
Jefferies Initiates Coverage On Biomea Fus...
08/28/2025 12:31:06

Jefferies analyst Roger Song initiates coverage on Biomea Fusion (NASDAQ:BMEA) with a Buy rating and announces Price Target ...

citigroup-maintains-buy-on-biomea-fusion-lowers-price-target-to-7
Citigroup Maintains Buy on Biomea Fusion, ...
08/11/2025 13:13:35

Citigroup analyst Yigal Nochomovitz maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and lowers the price target from $9 to $7.

scotiabank-maintains-sector-outperform-on-biomea-fusion-lowers-price-target-to-10
Scotiabank Maintains Sector Outperform on ...
08/06/2025 16:27:44

Scotiabank analyst George Farmer maintains Biomea Fusion (NASDAQ:BMEA) with a Sector Outperform and lowers the price target ...

d-boral-capital-maintains-buy-on-biomea-fusion-maintains-16-price-target
D. Boral Capital Maintains Buy on Biomea F...
08/06/2025 13:11:47

D. Boral Capital analyst Jason Kolbert maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and maintains $16 price target.

biomea-fusion-q2-eps-051-beats-054-estimate
Biomea Fusion Q2 EPS $(0.51) Beats $(0.54)...
08/05/2025 20:36:40

Biomea Fusion (NASDAQ:BMEA) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.54)...

d-boral-capital-maintains-buy-on-biomea-fusion-maintains-16-price-target
D. Boral Capital Maintains Buy on Biomea F...
07/21/2025 17:27:05

D. Boral Capital analyst Jason Kolbert maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and maintains $16 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION